Biomaterials for Cell Delivery

Vehicles in Regenerative Medicine

Aaron S. Goldstein (Virginia Tech University, Blacksburg, Virginia, USA)

$336

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

CRC Press Inc
10 December 2018

Medical equipment & techniques; Biomedical engineering; Cellular biology (cytology); Biotechnology

Series: Gene and Cell Therapy

The purpose of this book is to summarize key strategies and recent accomplishments in the area of developing cell/biomaterial constructs for regenerative medicine. The first section is a review of the state-of-the-art of biomaterial carriers and is divided into synthetic and natural materials. A subset of the latter are decellularized organs which retain the structure and some of the biological activities of the target organ. The bulk of the book is devoted to unique problems associated with key tissue and organ targets.

Key selling features:

Describes developing cell/biomaterial constructs for regenerative medicine Reviews state-of-the-art of biomaterial carriers Summarizes the unique problems associated with key tissue and organ targets Discusses issues associated with clinical translation including quality control, manufacturing practices, nondestructive imaging, and animal models

Edited by: Aaron S. Goldstein (Virginia Tech University Blacksburg Virginia USA)
Imprint: CRC Press Inc
Country of Publication: United States
Dimensions: Height: 234mm, Width: 156mm,
Weight: 716g
ISBN: 9781498743167
ISBN 10: 1498743161
Series: Gene and Cell Therapy
Pages: 341
Publication Date: 10 December 2018
Audience: General/trade , College/higher education , ELT Advanced , Primary
Format: Hardback
Publisher's Status: Active

Natural materials for cell-based therapies. Synthetic polymers for cell-based therapies. Decellularized tissues for bioengineering of whole organs. Cell-based approaches for vascularized tissue formation. Using biomaterials to deliver cells in vivo for neural tissue engineering applications.Cell carriers for bone and cartilage repair in vivo. Delivering therapeutic cells to the heart. In vivo cell delivery:Pancreatic islet transplantation. Cutaneous wound healing. Incorporaton of in vitro cell conditioning for enhanced development of tissue-engineered skeletal muscle implants. Conditioning cells in vitro to facilitate tendon and ligament regeneration. In vitro cell conditioning for the development of engineered blood vessels. Perspectives for clinical translation: How stem cells and biomaterials affect vasculogenesis and neurogenesis in preclinical and clinical models.

Aaron S. Goldstein, PhD, designs and evaluates two- and three-dimensional tissue microenvironments to guide stem cell differentiation into orthopedic tissue phenotypes. His research involves the combination of biocompatible materials and materials processing techniques to systematically and spatially vary the chemistry, topography, and mechanical properties of the biomaterial surfaces that are presented to cells. His interests also include the use of perfusion and mechanical stretch bioreactors to stimulate cell phenotypes through the activation of mechanotransductive signaling pathways. He is the author of more than 40 peer-reviewed research articles in the areas of biomaterials, cell adhesion, and tissue engineering. He earned a BS in chemical engineering from the University of California and a PhD in chemical and biomedical engineering from Carnegie Mellon University. He was a postdoctoral research fellow in the Department of Bioengineering at Rice University before joining the Department of Chemical Engineering at Virginia Tech in 1999.